2021
DOI: 10.1016/j.yjmcc.2021.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 46 publications
0
8
0
Order By: Relevance
“…The regulation of relevant signaling pathways is essential for the prevention and treatment of pathological heart hypertrophy. The research have shown that cardiac hypertrophy is regulated by multiple pathways, such as JAK/STAT, MAPK and PI3K (Varghese et al, 2022;Shen et al, 2021). However, PI3K is a critical enzyme in the induction of heart hypertrophy, interstitial brosis and cardiac dysfunction, while AKT1 is the main target of PI3K signaling and plays an important role in improving cardiac hypertrophy (Cheng et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…The regulation of relevant signaling pathways is essential for the prevention and treatment of pathological heart hypertrophy. The research have shown that cardiac hypertrophy is regulated by multiple pathways, such as JAK/STAT, MAPK and PI3K (Varghese et al, 2022;Shen et al, 2021). However, PI3K is a critical enzyme in the induction of heart hypertrophy, interstitial brosis and cardiac dysfunction, while AKT1 is the main target of PI3K signaling and plays an important role in improving cardiac hypertrophy (Cheng et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…The mice were infused with 1.44 mg/kg/d or 2.5 mg/kg/d Ang II (Sigma-Aldrich, Cat# A9525) for two weeks through subcutaneous osmotic minipumps (Model 2002, ALZA Scientific Products, Mountain View, CA, USA). These two doses of Ang II were chosen based on their well-known effects to induce vascular remodeling or abdominal aortic aneurysm and cardiac hypertrophy [ 17 19 ]. Saline-infused mice served as the controls.…”
Section: Methodsmentioning
confidence: 99%
“…Cardiac hypertrophy, an early pathological change in heart failure, is a response to increased load-induced ventricular wall pressure to maintain cardiac output and persistent myocardial hypertrophy eventually leads to decompensation 3,4 . There are many reasons for myocardial hypertrophy, such as angiotensin II 5 , stress-induced 6 or mediated by certain chemical substances 7 . Some adipokines are independent risk factors for cardiac hypertrophy 8,9 .…”
Section: Introductionmentioning
confidence: 99%